Literature DB >> 25356058

Association between Helicobacter pylori infection and migraine: a meta-analysis.

Jing Su1, Xiao-Ying Zhou1, Guo-Xin Zhang1.   

Abstract

AIM: To quantify the association between Helicobacter pylori (H. pylori) infection and migraine.
METHODS: A systematic literature search of PubMed and EMBASE was conducted from inception to December 2013. Studies that provided data dealing with H. pylori infection in patients with migraine, as well as healthy controls, were selected. Meta-analysis was carried out using the odds ratio (OR) with a fixed or random effects model, and a 95%CI for the OR was calculated. An unconditional logistic regression model was used to analyze potential parameters related to H. pylori prevalence. Subgroup analyses were conducted as methods of detection and evidence grade.
RESULTS: Five case-control studies published between 2000 and 2013 were finally identified, involving 903 patients, with a total H. pylori infection rate of 39.31%. The prevalence of H. pylori infection was significantly greater in migraineurs than in controls (44.97% vs 33.26%, OR = 1.92, 95%CI: 1.05-3.51, P = 0.001). A sensitivity test indicated that no single study dominated the combined results. Univariate regression analysis found that publication year, geographical distribution and evidence grade were relevant to the results and were the main reason for the heterogeneity. Subgroup analysis found a significantly greater infection rate of H. pylori in Asian patients with migraine, but no statistically significant infection rate in European patients. The ORs were 3.48 (95%CI: 2.09-5.81, P = 0.000) and 1.19 (95%CI: 0.86-1.65, P = 0.288), respectively.
CONCLUSION: The pooled data suggest a trend of more frequent H. pylori infections in patients with migraine.

Entities:  

Keywords:  Helicobacter pylori; Meta-analysis; Migraine; Odds ratio; Subgroup analysis

Mesh:

Year:  2014        PMID: 25356058      PMCID: PMC4209561          DOI: 10.3748/wjg.v20.i40.14965

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  40 in total

1.  Migraine in childhood.

Authors:  M A Salmon
Journal:  Nurs Mirror       Date:  1977-08-11

2.  Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors:  R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

3.  Migraine, Helicobacter pylori, and oxidative stress.

Authors:  Ayşe Tunca; Yasemin Ardiçoğlu; Ayşe Kargili; Bahattin Adam
Journal:  Helicobacter       Date:  2007-02       Impact factor: 5.753

4.  Association between Helicobacter pylori cytotoxic type I CagA-positive strains and migraine with aura.

Authors:  A Gasbarrini; M Gabrielli; G Fiore; M Candelli; F Bartolozzi; A De Luca; F Cremonini; F Franceschi; C Di Campli; A Armuzzi; V Ojetti; M Serricchio; R Pola; G Gasbarrini; M Giacovazzo; P Pola
Journal:  Cephalalgia       Date:  2000-07       Impact factor: 6.292

5.  Effect of chocolate in migraine: a double-blind study.

Authors:  A M Moffett; M Swash; D F Scott
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

6.  Helicobacter pylori alters exogenous antigen absorption and processing in a digestive tract epithelial cell line model.

Authors:  T Matysiak-Budnik; K Terpend; S Alain; M J Sanson le Pors; J F Desjeux; F Mégraud; M Heyman
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

7.  The effect of Helicobacter pylori eradication on migraine: a randomized, double blind, controlled trial.

Authors:  Fardin Faraji; Nader Zarinfar; Afsoon Talaie Zanjani; Afsaneh Morteza
Journal:  Pain Physician       Date:  2012 Nov-Dec       Impact factor: 4.965

8.  Cerebral oxygen extraction, oxygen consumption, and regional cerebral blood flow during the aura phase of migraine.

Authors:  L Friberg; J Olesen; N A Lassen; T S Olsen; A Karle
Journal:  Stroke       Date:  1994-05       Impact factor: 7.914

Review 9.  Chemokine expression in Helicobacter pylori-infected gastric mucosa.

Authors:  T Shimada; A Terano
Journal:  J Gastroenterol       Date:  1998-10       Impact factor: 7.527

10.  Evaluation of Helicobacter pylori infection in patients with common migraine headache.

Authors:  Morteza Hosseinzadeh; Afra Khosravi; Kourosh Saki; Reza Ranjbar
Journal:  Arch Med Sci       Date:  2011-11-08       Impact factor: 3.318

View more
  13 in total

1.  On the Association between Gastrointestinal Symptoms and Extragastric Manifestations.

Authors:  G Naoum; S L Markantonis; E Fanerou; G Siagkas; F Petropoulos; E Zafiris; R Kousovista; V Karalis
Journal:  Gastroenterol Res Pract       Date:  2022-06-18       Impact factor: 1.919

Review 2.  Migraine, Cyclic Vomiting Syndrome, and Other Gastrointestinal Disorders.

Authors:  Elliot S Yu; Yasodara Priyadharsini S S; Thangam Venkatesan
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

Review 3.  Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology.

Authors:  Douglas Kell; Marnie Potgieter; Etheresia Pretorius
Journal:  F1000Res       Date:  2015-07-01

4.  Clinical Implications of Associations between Headache and Gastrointestinal Disorders: A Study Using the Hallym Smart Clinical Data Warehouse.

Authors:  Sang-Hwa Lee; Jae-June Lee; Youngsuk Kwon; Jong-Ho Kim; Jong-Hee Sohn
Journal:  Front Neurol       Date:  2017-10-03       Impact factor: 4.003

5.  Association between H. pylori infection and health Outcomes: an umbrella review of systematic reviews and meta-analyses.

Authors:  Liqun Li; Jinjing Tan; Lijian Liu; Jianfeng Li; Guangwen Chen; Mingbing Chen; Jieru Xie; Qingzeng Song; Xiaoyan Huang; Sheng Xie
Journal:  BMJ Open       Date:  2020-01-09       Impact factor: 2.692

Review 6.  Gut-brain Axis and migraine headache: a comprehensive review.

Authors:  Mahsa Arzani; Soodeh Razeghi Jahromi; Zeinab Ghorbani; Fahimeh Vahabizad; Paolo Martelletti; Amir Ghaemi; Simona Sacco; Mansoureh Togha
Journal:  J Headache Pain       Date:  2020-02-13       Impact factor: 7.277

7.  STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD® ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients.

Authors:  Timothy R Smith; Paul Winner; Sheena K Aurora; Maria Jeleva; Jasna Hocevar-Trnka; Stephen B Shrewsbury
Journal:  Headache       Date:  2021-08-07       Impact factor: 5.311

Review 8.  Gastrointestinal disorders associated with migraine: A comprehensive review.

Authors:  Carlos R Cámara-Lemarroy; Rene Rodriguez-Gutierrez; Roberto Monreal-Robles; Alejandro Marfil-Rivera
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

9.  Migraine and gastric disorders: Are they associated?

Authors:  Ahmad Hormati; Nayyereh Akbari; Ehsan Sharifipour; Seyyed Amir Hejazi; Fatemeh Jafari; Faezeh Alemi; Abolfaz Mohammadbeigi
Journal:  J Res Med Sci       Date:  2019-07-24       Impact factor: 1.852

Review 10.  A link between gastrointestinal disorders and migraine: Insights into the gut-brain connection.

Authors:  Sheena K Aurora; Stephen B Shrewsbury; Sutapa Ray; Nada Hindiyeh; Linda Nguyen
Journal:  Headache       Date:  2021-04-01       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.